A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension

NCT07152444 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Hypertension

Interventions

DRUG: QLS1410 (CYP11B2 inhibitor)
DRUG: placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.